+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

Vaccine Adjuvants - Global Strategic Business Report - Product Thumbnail Image

Vaccine Adjuvants - Global Strategic Business Report

  • Report
  • July 2025
  • 193 Pages
  • Global
From
Ebola Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Drugs and Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 485 Pages
  • Global
From
Subunit Vaccines - Global Strategic Business Report - Product Thumbnail Image

Subunit Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 279 Pages
  • Global
From
Vaccine Technologies - Global Strategic Business Report - Product Thumbnail Image

Vaccine Technologies - Global Strategic Business Report

  • Report
  • July 2025
  • 573 Pages
  • Global
From
From
Rotavirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Rotavirus Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 277 Pages
  • Global
From
Digital Vaccines - Global Strategic Business Report - Product Thumbnail Image

Digital Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 274 Pages
  • Global
From
From
Adult Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adult Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 377 Pages
  • Global
From
Adenovirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adenovirus Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 279 Pages
  • Global
From
Malaria Vaccines - Global Strategic Business Report - Product Thumbnail Image

Malaria Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 371 Pages
  • Global
From
Preventable Vaccines - Global Strategic Business Report - Product Thumbnail Image

Preventable Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 391 Pages
  • Global
From
Inactivated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 468 Pages
  • Global
From
Ebola Virus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Virus Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 336 Pages
  • Global
From
COVID-19 Vaccines - Global Strategic Business Report - Product Thumbnail Image

COVID-19 Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 762 Pages
  • Global
From
The World Market for Vaccines, 2024 - Product Thumbnail Image

The World Market for Vaccines, 2024

  • Report
  • February 2024
  • 202 Pages
  • Global
From
Loading Indicator